| NDC Code | 12064-018-01 |
|---|
| Package Description | 1 VIAL in 1 CARTON (12064-018-01) > 1 mL in 1 VIAL |
|---|
| Product NDC | 12064-018 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Nucala |
|---|
| Non-Proprietary Name | Mepolizumab |
|---|
| Dosage Form | INJECTION, POWDER, FOR SOLUTION |
|---|
| Usage | SUBCUTANEOUS |
|---|
| Start Marketing Date | 20151104 |
|---|
| Marketing Category Name | APPROVED DRUG PRODUCT MANUFACTURED UNDER CONTRACT |
|---|
| Application Number | BLA125526 |
|---|
| Manufacturer | GlaxoSmithKline Manufacturing SpA |
|---|
| Substance Name | MEPOLIZUMAB |
|---|
| Strength | 100 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Interleukin-5 Antagonist [EPC],Interleukin-5 Antagonists [MoA] |
|---|